Newsroom

Dr. Quentin Marlier, head of biology at Dendrogenix and ESO member, will present a poster publication entitled “Improvement of neurological outcomes following Stroke in mice treated with a novel first-in-class compound” to expose preclinical data regarding its lead compound DX243 in Stroke. European Stroke Organisation Conference (ESOC) is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2025 will take place from 21–23 May 2025 in Helsinki, Finland.